Asymmetry Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
New Culture produces animal-free dairy cheese products, starting with mozzarella for pizzerias, using food science to replicate the taste, melt, and stretch of conventional cheese.
Climate TechFoodTechSan Leandro, US
Matthew Gibson(Executive Officer, Director)inInja Radman(Founder)inMatt Gibson(Founder)inMatt Gibson Inja Radman(Founder)
BoardSteve Sanger(Director)
PartnerRob Ness· solo GP
Co-investorsAhren Innovation CapitalBee PartnersBluestein VenturesGenoa VenturesS2G InvestmentsSynthesis Capital+2 more
Promakhos Therapeutics develops immunomodulatory therapies to restore immune system balance and reduce chronic inflammation in diseases like Crohn's disease, ankylosing spondylitis, and psoriasis.
BiotechHealthtechBoston, US
Katerina Chatzi(Founder)inJasper Edgar Neggers(Founder)inAIKATERINI CHATZI(Executive Officer, Director, Promoter)Katerina Chatzi, PhD(Founder)inKaterina Chatzi, Ph.D.(Co-founder, Chief Executive Officer and President)inJasper E. Neggers, Ph.D.(Co-Founder, Chief Scientific Officer and Secretary)
Co-investorsFoundersGaingelsMetaplanetMULTIMODAL VENTURESPioneerY Combinator+7 more
Stayflexi provides software that handles operations for hotels and vacation rentals, with features for automating management tasks and selling unused rooms and amenities to increase revenue.
Enterprise SoftwareSan Francisco, US
Venkatesh Sakamuri(Founder)inPreetam Mohan Shetty(Founder)inKrishna Sasank Talasila(Founder)inBinay Kumar(EVP)Swati Singh(HR)Amit Pandey(CGO)
Co-investorsDERIVE VENTURESGood News VenturesY CombinatorBlue Field CapitalGreat Wave Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














__Twitter.png)








